MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients With Triple Negative or HER2+ MBC
Conditions: Breast Neoplasm; Brain Metastases; Triple Negative Breast Cancer; HER2-positive Breast Cancer Intervention: Diagnostic Test: MRI screening Sponsors: Sunnybrook Health Sciences Centre; Harvard University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials